Equifax
EFX stock analysis · Industrials · Research & Consulting Services
As of · fund-implied per-share value
Fund holding value ÷ shares held. Not a live quote; not adjusted for later stock splits.
View SEC fund filing ↗Price × SEC outstanding shares. Shares measured 2026-06-30. Approximate; share and price dates can differ.
View share-count filing ↗DCF value
Equity cash-flow scenario · SEC outstanding shares at 2026-06-30 · -7.7% versus input cap
How this is calculated ↗Reverse DCF
Annual basis · read assumptions below
How this is calculated ↗Relative valuation
76 sector peers · median 31.7×
How this is calculated ↗Historical multiples
6 annual observations · snapshot P/E 28.3× · -35.0% versus history
How this is calculated ↗Free cash flow yield
Annual basis · read assumptions below
How this is calculated ↗ROIC / quality
Normalized tax · financing-capital proxy · short-term borrowing coverage incomplete
How this is calculated ↗Value composite
Annual basis · read assumptions below
How this is calculated ↗12–1 price momentum
Split and corporate-action verification is incomplete for these fund observations. Verified adjusted endpoints are required for 12–1 momentum.
How this is calculated ↗Asset growth
Annual basis · read assumptions below
How this is calculated ↗Net payout yield
Annual basis · read assumptions below
How this is calculated ↗Accrual quality
Annual basis · read assumptions below
How this is calculated ↗Fundamental momentum
Annual basis · read assumptions below
How this is calculated ↗Follow the cash
ANNUAL · USDOperating cash flow and reinvestment over time
Annual USD. Negative bars use a compressed lower scale. Hover or inspect the financial history table for exact values.
Make the assumptions yours
How sensitive is the valuation?
| Return / Growth | 3.0% | 5.0% | 7.0% |
|---|---|---|---|
| 8.0% | $183.75 | $200.49 | $218.49 |
| 10.0% | $134.65 | $146.50 | $159.22 |
| 12.0% | $106.23 | $115.27 | $124.96 |
Annual financial history
Open SEC filings ↗| Fiscal year-end | Revenue | Net income | Operating cash flow | Capital expenditure | Assets |
|---|---|---|---|---|---|
| 2025-12-31 | 6.1B | 664.3M | 1.6B | 481.4M | 11.9B |
| 2024-12-31 | 5.7B | 607.3M | 1.3B | 511.5M | 11.8B |
| 2023-12-31 | 5.3B | 551.7M | 1.1B | 601.3M | 12.3B |
| 2022-12-31 | 5.1B | 700.2M | 757.1M | 624.5M | 11.5B |
| 2021-12-31 | 4.9B | 748.5M | 1.3B | 469M | 11B |
| 2020-12-31 | 4.1B | 526.2M | 946.2M | 421.3M | 9.6B |
| 2019-12-31 | 3.5B | -378.1M | 313.8M | 399.6M | 7.9B |
| 2018-12-31 | 3.4B | 317M | 672.2M | 321.9M | 7.2B |
USD, abbreviated. Restated annual history; not a point-in-time backtest. Missing values appear as dashes.
Trace the inputs
MODEL ANNUAL PERIOD| Input | Value | SEC tag / source | Filed |
|---|---|---|---|
| revenue | 6.1B | RevenueFromContractWithCustomerExcludingAssessedTax | 2026-02-19 |
| netIncome | 664.3M | ProfitLoss Explicit consolidated amount, including the portion attributable to noncontrolling interests. | 2026-02-19 |
| Parent/common earnings proxy | 660.3M | NetIncomeLoss | 2026-02-19 |
| cfo | 1.6B | NetCashProvidedByUsedInOperatingActivities | 2026-02-19 |
| capex | 481.4M | PaymentsToAcquireProductiveAssets | 2026-02-19 |
| operatingIncome | 1.1B | OperatingIncomeLoss | 2026-02-19 |
| assets | 11.9B | Assets | 2026-02-19 |
| equity | 4.6B | StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest Explicit consolidated amount, including the portion attributable to noncontrolling interests. | 2026-02-19 |
| Parent book equity proxy | 4.6B | StockholdersEquity | 2026-02-19 |
| debt | 5.1B | LongTermDebt | 2026-02-19 |
| shortDebt | — | Not reported under a supported tag | — |
| cash | 180.8M | CashAndCashEquivalentsAtCarryingValue | 2026-02-19 |
| shares | 124.1M | WeightedAverageNumberOfDilutedSharesOutstanding | 2026-02-19 |
| dividends | 232.8M | PaymentsOfDividendsCommonStock | 2026-02-19 |
| buybacks | 927.5M | PaymentsForRepurchaseOfCommonStock | 2026-02-19 |
| issuance | 46.4M | Reviewed manual correction Bounded FY2025-12-31 consolidated financing-statement extraction. Proceeds from exercise of stock options and employee stock purchase plan: 46400000 USD [us-gaap:ProceedsFromStockOptionsExercised]. All 10 financing lines reconcile exactly to reported financing cash flow -1059700000 USD. Cash inflows from common shares, employee plans and option exercises are summed once as displayed on the statement; noncash compensation, withholding payments, preferred and noncontrolling interests are excluded. This review applies only to this issuer and fiscal period. Source limitation: issuance follows the separately reported common cash-inflow lines; it is not an independent verification of every gross equity transaction. | 2026-02-19 |